Thirty Madison is a full-service healthcare company in New York that focuses on providing medications. Founded 2017 in New York, United States by Demetri Karagas and Steven Gutentag, Thirty Madison has raised a total of $22.8M in funding over two rounds. Their latest funding was raised on October 16, 2018 from a Series A round. Thirty Madison is funded by 8 investors. As of March 2020, Steadfast Venture Capital and Greycroft are the most recent investors. Thirty Madison combines virtual diagnosis and FDA-approved treatments to create access to preventative medicine and care for men experiencing hair loss.